Drugs / AZD1419
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02898662 | Oct 2016 → Sep 2018 | asthma | AstraZeneca | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD1419 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02898662 ↗ |
| Route | Inhaled | “Inhaled AZD1419 administered at the clinic” NCT02898662 ↗ |